文献速递胸部心血管外周血管CT

非增强CT肺血管分析评估慢性血栓栓塞性肺动脉高压治疗反应

Treatment Response Evaluation by Computed Tomography Pulmonary Vasculature Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension.
PubMed 文献 · Korean J Radiol · 2023-03-07

本研究纳入30例接受多模式治疗(利奥西呱±球囊肺血管成形术)的慢性血栓栓塞性肺动脉高压患者,于治疗前后行非增强CT肺血管定量分析和右心导管检查。治疗后胸膜下小血管数量、面积和密度增加,BV5/TBV比值升高且与肺血管阻力、心指数及临床指标相关,提示非增强CT可定量评估肺血管治疗反应。

要点

  • 非增强CT可定量评估CTEPH治疗前后肺小血管血容量变化。
  • BV5/TBV比值变化与mPAP、PVR变化及心功能指标相关。
  • 胸膜下小血管数量、面积、密度在治疗后显著增加。

关键影像表现/征象

  • 治疗后胸膜下小血管数量增加35.7%(P < 0.001),面积增加13.3%(P = 0.028),密度增加39.3%(P < 0.001)。
  • BV5/TBV比值增加11.3%(P = 0.042),提示血容量从较大血管向较小血管转移。

诊断标准与关键数值

  • BV5定义为横截面积≤ 5 mm²的小血管内血容量,TBV为全肺总血容量。
  • BV5/TBV比值与PVR负相关(r = -0.26;P = 0.035),与CI正相关(r = 0.33;P = 0.009)。
  • BV5/TBV比值变化百分比与mPAP变化百分比负相关(r = -0.56;P = 0.001),与PVR变化百分比负相关(r = -0.64;P < 0.001),与CI变化百分比正相关(r = 0.28;P = 0.049)。
  • BV5/TBV比值与WHO功能分级I-IV呈负相关(P = 0.004),与6MWD正相关(P = 0.013)。

临床应用与阅片要点

  • 可利用非增强CT定量分析胸膜下小血管参数(BV5/TBV比值)辅助评估CTEPH治疗反应。
  • BV5/TBV比值变化与血流动力学改善相关,可作为无创随访指标参考。

局限性

  • 样本量较小(30例),单中心研究。
  • 原文未报告敏感度、特异度、AUC或诊断阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To quantitatively assess the pulmonary vasculature using non-contrast computed tomography (CT) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) pre- and post-treatment and correlate CT-based parameters with right heart catheterization (RHC) hemodynamic and clinical parameters.

MATERIALS AND METHODS: A total of 30 patients with CTEPH (mean age, 57.9 years; 53% female) who received multimodal treatment, including riociguat for ≥ 16 weeks with or without balloon pulmonary angioplasty and underwent both non-contrast CT for pulmonary vasculature analysis and RHC pre- and post-treatment were included. The radiographic analysis included subpleural perfusion parameters, including blood volume in small vessels with a cross-sectional area ≤ 5 mm² (BV5) and total blood vessel volume (TBV) in the lungs. The RHC parameters included mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), and cardiac index (CI). Clinical parameters included the World Health Organization (WHO) functional class and 6-minute walking distance (6MWD).

RESULTS: The number, area, and density of the subpleural small vessels increased after treatment by 35.7% (P < 0.001), 13.3% (P = 0.028), and 39.3% (P < 0.001), respectively. The blood volume shifted from larger to smaller vessels, as indicated by an 11.3% increase in the BV5/TBV ratio (P = 0.042). The BV5/TBV ratio was negatively correlated with PVR (r = -0.26; P = 0.035) and positively correlated with CI (r = 0.33; P = 0.009). The percent change across treatment in the BV5/TBV ratio correlated with the percent change in mPAP (r = -0.56; P = 0.001), PVR (r = -0.64; P < 0.001), and CI (r = 0.28; P = 0.049). Furthermore, the BV5/TBV ratio was inversely associated with the WHO functional classes I-IV (P = 0.004) and positively associated with 6MWD (P = 0.013).

CONCLUSION: Non-contrast CT measures could quantitatively assess changes in the pulmonary vasculature in response to treatment and were correlated with hemodynamic and clinical parameters.

来源:Korean J Radiol,查看原文。版权归原作者所有。

引用

  1. Huang, Chen, Lee, et al. Treatment Response Evaluation by Computed Tomography Pulmonary Vasculature Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension. Korean J Radiol. 2023. PMID: 36907594. doi:10.3348/kjr.2022.0675

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。